Literature DB >> 17698509

Xenobiotic transporters: ascribing function from gene knockout and mutation studies.

Curtis D Klaassen1, Hong Lu.   

Abstract

Transporter-mediated absorption, secretion, and reabsorption of chemicals are increasingly recognized as important determinants in the biological activities of many xenobiotics. In recent years, the rapid progress in generating and characterizing mice with targeted deletion of transporters has greatly increased our knowledge of the functions of transporters in the pharmacokinetics/toxicokinetics of xenobiotics. In this introduction, we focus on functions of transporters learned from experiments on knockout mice as well as humans and rodents with natural mutations of these transporters. We limit our discussion to transporters that either directly transport xenobiotics or are important in biliary excretion or cellular defenses, namely multidrug resistance, multidrug resistance-associated proteins, breast cancer resistance protein, organic anion transporting polypeptides, organic anion transporters, organic cation transporters, nucleoside transporters, peptide transporters, bile acid transporters, cholesterol transporters, and phospholipid transporters, as well as metal transporters. Efflux transporters in intestine, liver, kidney, brain, testes, and placenta can efflux xenobiotics out of cells and serve as barriers against the entrance of xenobiotics into cells, whereas many xenobiotics enter the biological system via uptake transporters. The functional importance of a given transporter in each tissue depends on its substrate specificity, expression level, and the presence/absence of other transporters with overlapping substrate preferences. Nevertheless, a transporter may affect a tissue independent of its local expression by altering systemic metabolism. Further studies on the gene regulation and function of transporters, as well as the interrelationship between transporters and phase I/II xenobiotic-metabolizing enzymes, will provide a complete framework for developing novel strategies to protect us from xenobiotic insults.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17698509     DOI: 10.1093/toxsci/kfm214

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  35 in total

1.  Effects of aging on mRNA profiles for drug-metabolizing enzymes and transporters in livers of male and female mice.

Authors:  Zidong Donna Fu; Iván L Csanaky; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2012-03-23       Impact factor: 3.922

Review 2.  Drug uptake systems in liver and kidney: a historic perspective.

Authors:  B Hagenbuch
Journal:  Clin Pharmacol Ther       Date:  2009-11-18       Impact factor: 6.875

3.  Molecular characterization of zebrafish Oatp1d1 (Slco1d1), a novel organic anion-transporting polypeptide.

Authors:  Marta Popovic; Roko Zaja; Karl Fent; Tvrtko Smital
Journal:  J Biol Chem       Date:  2013-10-14       Impact factor: 5.157

Review 4.  Membrane transporters in drug development.

Authors:  Kathleen M Giacomini; Shiew-Mei Huang; Donald J Tweedie; Leslie Z Benet; Kim L R Brouwer; Xiaoyan Chu; Amber Dahlin; Raymond Evers; Volker Fischer; Kathleen M Hillgren; Keith A Hoffmaster; Toshihisa Ishikawa; Dietrich Keppler; Richard B Kim; Caroline A Lee; Mikko Niemi; Joseph W Polli; Yuichi Sugiyama; Peter W Swaan; Joseph A Ware; Stephen H Wright; Sook Wah Yee; Maciej J Zamek-Gliszczynski; Lei Zhang
Journal:  Nat Rev Drug Discov       Date:  2010-03       Impact factor: 84.694

5.  In vivo-in vitro-in silico pharmacokinetic modelling in drug development: current status and future directions.

Authors:  Olavi Pelkonen; Miia Turpeinen; Hannu Raunio
Journal:  Clin Pharmacokinet       Date:  2011-08       Impact factor: 6.447

6.  Effect of nine diets on xenobiotic transporters in livers of mice.

Authors:  Ying Guo; Julia Yue Cui; Hong Lu; Curtis D Klaassen
Journal:  Xenobiotica       Date:  2015-01-08       Impact factor: 1.908

Review 7.  ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.

Authors:  M J Zamek-Gliszczynski; C A Lee; A Poirier; J Bentz; X Chu; H Ellens; T Ishikawa; M Jamei; J C Kalvass; S Nagar; K S Pang; K Korzekwa; P W Swaan; M E Taub; P Zhao; A Galetin
Journal:  Clin Pharmacol Ther       Date:  2013-02-25       Impact factor: 6.875

Review 8.  Molecular mechanisms of microcystin toxicity in animal cells.

Authors:  Alexandre Campos; Vitor Vasconcelos
Journal:  Int J Mol Sci       Date:  2010-01-21       Impact factor: 6.208

Review 9.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

10.  Characterization of organic anion transporting polypeptide 1b2-null mice: essential role in hepatic uptake/toxicity of phalloidin and microcystin-LR.

Authors:  Hong Lu; Supratim Choudhuri; Kenichiro Ogura; Iván L Csanaky; Xiaohong Lei; Xingguo Cheng; Pei-zhen Song; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2008-02-21       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.